Skip to search formSkip to main contentSkip to account menu

fondaparinux

Known as: fondaparinux [Chemical/Ingredient] 
A synthetic glucopyranoside with antithrombotic activity. Fondaparinux selectively binds to antithrombin III, thereby potentiating the innate… 
National Institutes of Health

Related topics

Related topics

18 relations
0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]0.8 ML Fondaparinux sodium 12.5 MG/ML Prefilled SyringeBacterial EndocarditisDrug Allergy

Broader (2)

AnticoagulantsPolysaccharides

Narrower (1)

Arixtra

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Highly Cited
2014
Highly Cited
2014
Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests
Abstract Background: In recent years, several selectively acting anticoagulants, including the direct thrombin inhibitors (DTI… 
Highly Cited
2014
Highly Cited
2014
Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71
ABSTRACT Enterovirus 71 (EV71) is a highly transmissible pathogenic agent that causes severe central nervous system diseases in… 
Review
2011
Review
2011
Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy.
The actual incidence of neurological dysfunction resulting from haemorrhagic complications associated with neuraxial block is… 
Highly Cited
2010
Highly Cited
2010
An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma
An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma - 
Review
2007
Review
2007
Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment.
Thrombophilia is a well-described consequence of cancer and its treatment. The pathogenesis of this phenomenon is complex and… 
Highly Cited
2007
Highly Cited
2007
Fondaparinux for the treatment of patients with acute heparininduced thrombocytopenia
Summary Heparin-induced thrombocytopenia (HIT) is a life-threatening immune response to heparin that is associated with a high… 
Highly Cited
2005
Highly Cited
2005
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4… 
Highly Cited
2005
Highly Cited
2005
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.
Heparin-induced thrombocytopenia (HIT) is a complication of heparin therapy caused by antibodies against a complex of platelet… 
Highly Cited
2003
Highly Cited
2003
Prevention of venous thromboembolism in high risk abdominal surgery
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)